NAC to help bone marrow recovery in severe aplastic anemia
Part of Blood & lymphatic clinical trials.
This trial tests whether N-acetylcysteine (NAC), a common supplement, can help your bone marrow recover faster after a stem cell transplant for severe aplastic anemia. If you qualify, you'll receive NAC alongside your standard transplant care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with severe aplastic anemia (SAA) or very severe aplastic anemia (vSAA).
- Your age must be between 18 and 50 years old.
- You should not have any serious damage to your heart, liver, kidneys, or lungs.
- You cannot have an active infection that is not under control.
- You must be willing to sign a consent form and follow the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a medication called N-acetylcysteine (NAC) before a half-matched stem cell transplant can help your body make new platelets faster. Platelets are blood cells that help prevent bleeding, which is a common problem after transplant for severe aplastic anemia.
This trial tests a “half-matched” stem cell transplant for children and teens with severe aplastic anemia when a fully matched donor isn’t available. It may help rebuild blood-making cells after prior treatments did not work well enough.
This study is testing whether a stem cell transplant (from a matched relative, unrelated donor, or half-matched donor) can help adults aged 40–60 with severe aplastic anemia that didn't get better or came back after standard treatments.
This trial tests a new approach: first, you receive a specially engineered immune cell treatment (CD7 CAR-T) to help prepare your body, then a stem cell transplant from a relative. It's designed for people with severe aplastic anemia who cannot have or choose not to get a standard transplant.
This trial tests whether an early bone marrow transplant from a half-matched family member or an unrelated donor can help people with severe aplastic anemia. It aims to restore the body's ability to make healthy blood cells.
This trial tests two different sources of donor cells for a transplant in patients with severe aplastic anemia (a condition where the bone marrow stops making enough blood cells). The study compares using cells from blood alone versus cells from both bone marrow and blood, to see which approach works better.
Hear when a new Aplastic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.